MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients

Lukamowicz-Rajska, Magdalena; Mittmann, Christiane; Prummer, Michael; Zhong, Qing; Bedke, Jens; Stenzl, Arnulf; Mischo, Axel; Bihr, Svenja; Schmidinger, Manuela; Vogl, Ursula; Blume, Iris; Karlo, Christoph; Schraml, Peter; Moch, Holger; Hennenlotter, Jörg

dc.contributor.author	Bedke, Jens
dc.contributor.author	Stenzl, Arnulf
dc.contributor.author	Hennenlotter, Jörg
dc.date.accessioned	2018-09-18T08:22:21Z
dc.date.available	2018-09-18T08:22:21Z
dc.date.issued	2016
dc.identifier.issn	1949-2553
dc.identifier.uri	http://hdl.handle.net/10900/84222
dc.language.iso	en	de_DE
dc.publisher	Impact Journals Llc	de_DE
dc.relation.uri	http://dx.doi.org/10.18632/oncotarget.12618	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients	de_DE
dc.type	Article	de_DE
utue.quellen.id	20180405102126_00320
utue.publikation.seiten	78433-78447	de_DE
utue.personen.roh	Lukamowicz-Rajska, Magdalena
utue.personen.roh	Mittmann, Christiane
utue.personen.roh	Prummer, Michael
utue.personen.roh	Zhong, Qing
utue.personen.roh	Bedke, Jens
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Mischo, Axel
utue.personen.roh	Bihr, Svenja
utue.personen.roh	Schmidinger, Manuela
utue.personen.roh	Vogl, Ursula
utue.personen.roh	Blume, Iris
utue.personen.roh	Karlo, Christoph
utue.personen.roh	Schraml, Peter
utue.personen.roh	Moch, Holger
utue.personen.roh	Hennenlotter, Jörg
dcterms.isPartOf.ZSTitelID	Oncotarget	de_DE
dcterms.isPartOf.ZS-Issue	48	de_DE
dcterms.isPartOf.ZS-Volume	7	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE